Search

Author/Creator Prusila, Roosa

1. Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma. Issue 10 (24th August 2019)

Authors:
Sorigue, Marc; Bishton, Mark; Domingo-Domenech, Eva; McMillan, Andrew; Prusila, Roosa; García, Olga; Kuusisto, Milla; Condom, Maria; Tapia, Gustavo; Ribera, Josep-María; Kuittinen, Outi; Fox, Christopher P.; Sancho, Juan-Manuel
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 10(2019)
Page Start:
2524
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020. (13th December 2022)

Authors:
Harmanen, Minna; Hujo, Mika; Sund, Reijo; Sorigue, Marc; Khan, Madiha; Prusila, Roosa; Klaavuniemi, Tuula; Kari, Esa; Jantunen, Esa; Sunela, Kaisa; Rajamäki, Aino; Alanne, Erika; Kuitunen, Hanne; Sancho, Juan‐Manuel; Jukkola, Arja; Rönkä, Aino; Kuittinen, Outi
Journal:
British journal of haematology
Issue:
Volume 201:Number 1(2023)
Page Start:
64
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search